Listen

Description

Davinderpreet Mangat, David Dahan, and Ellie Davenport discuss new developments in the diffuse large B-cell lymphoma (DLBCL) and melanoma space.

Topics covered include:
• DLBCL – CAR-T therapies: 1:23
• DLBCL – Polivy: 12:40
• Melanoma – Lifileucel: 20:20
• Melanoma – Keytruda: 27:25

Supporting links:

https://service.datamonitorhealthcare.com/hkc/disease/oncology/lymphoma/diffuse-large-B-cell-lymphoma/
https://service.datamonitorhealthcare.com/hkc/disease/oncology/skin-cancer/malignant-melanoma/disease-analysis/article223365.ece
https://www.biomedtracker.com/EventDetail.cfm?EventID=416767
https://www.biomedtracker.com/EventDetail.cfm?EventID=418078
https://www.biomedtracker.com/EventDetail.cfm?EventID=422214
https://www.biomedtracker.com/EventDetail.cfm?EventID=421354
https://www.biomedtracker.com/EventDetail.cfm?EventID=421183

Other platforms:

Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836
Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz
TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/
Spotify Podcasts - https://open.spotify.com/show/3DTc3eIh4xI6pVOd6DdO67